Lansdale, PA, United States of America

Gregg Wesolowski

This inventor holds 3 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1998-2000.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Osteoclast Research by Gregg Wesolowski

Introduction

Gregg Wesolowski is a notable inventor based in Lansdale, PA, who has made significant contributions to the field of osteoclast research. With a total of three patents to his name, Wesolowski's work focuses on methods that enhance the understanding of bone resorption activity.

Latest Patents

Wesolowski's latest patents include innovative techniques such as a method of measuring bone resorption activity with a highly enriched population of osteoclast cells. He has also developed a method for producing a highly enriched population of osteoclast precursor cells, which can be released from tissue culture dishes for biochemical studies. His research involves co-culturing osteoblastic cells and bone marrow cells, followed by the use of an alpha_v beta_3 receptor ligand, such as echistatin, for cell detachment. This process results in a 75-95% pure enriched population of tartrate-resistant acid phosphatase (TRAP^+) cells, yielding 2-3 million cells per experiment. These cells are primarily mononucleated and are classified as pre-fusion osteoclasts (pOC cells). Furthermore, the precursor osteoclasts can be reseeded onto osteoblasts to obtain an enriched population of mature, multinucleated osteoclast cells.

Career Highlights

Wesolowski is currently associated with Merck & Company, Inc., where he continues to advance his research in osteoclast biology. His work has implications for understanding bone diseases and developing therapeutic strategies.

Collaborations

Throughout his career, Wesolowski has collaborated with esteemed colleagues such as Sevgi B Rodan and Gideon A Rodan, contributing to the advancement of knowledge in his field.

Conclusion

Gregg Wesolowski's innovative research and patents in osteoclast biology highlight his significant role in advancing the understanding of bone resorption and its implications for health. His contributions continue to influence the field and pave the way for future discoveries.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…